Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung CancerNCT04620330VSTMPhase 2Completed2023-08-29Actual
Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular AllergiesNCT04622345Vanda PharmaceuticalsPhase 2Completed2021-05-22Actual
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS MutationNCT04625270VSTMPhase 2Active not recruiting2024-11-15Actual
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 SubjectsNCT04629703Rigel PharmaceuticalsPhase 3Completed2022-09-05Actual
Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMDNCT04632940Kyntra BioPhase 3Terminated2023-06-12Actual
A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With ImatinibNCT04633122Zai Lab (Shanghai) Co., Ltd.Phase 2Completed2022-07-20Actual
Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory TractNCT04633187ENTAPhase 2Terminated2023-05-31Actual
Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)NCT04634669AXSMPhase 2Terminated2022-02-18Actual
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck CancerNCT04634825MacroGenicsPhase 2Terminated2022-07-29Actual
Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the KneeNCT04636229OrganogenesisPhase 3Completed2023-07-30Actual
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic EncephalopathyNCT04639310XENEPhase 3Terminated2023-05-16Actual
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposureNCT04642638Inovio PharmaceuticalsPhase 2, Phase 3Terminated2022-09-13Actual
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)NCT04652882Vanda PharmaceuticalsPhase 3Active not recruiting2026-09Estimated
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)NCT04655313ARQTPhase 2Completed2022-01-12Actual
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic AtrophyNCT04656561ANNXPhase 2Completed2023-03-28Actual
Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisNCT04657666Jazz PharmaceuticalsPhase 3Completed2022-05-04Actual
A Study of Auxora in Patients With Critical COVID-19 PneumoniaNCT04661540CALCPhase 2Terminated2021-12-21Actual
Efficacy and Safety of LX9211 in Participants With Postherpetic NeuralgiaNCT04662281Lexicon PharmaceuticalsPhase 2Completed2022-11-18Actual
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)NCT04663308MIRMPhase 2Active not recruiting2026-02-20Actual
A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy AdultsNCT04668339Arcturus Therapeutics, Inc.Phase 2Terminated2022-03-01Actual
A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseNCT04669028BIVIPhase 3Completed2023-09-30Actual
The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseNCT04674358ALDXPhase 2, Phase 3Completed2021-09-12Actual
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)NCT04675294ALX Oncology Inc.Phase 2Active not recruiting2025-03-03Actual
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)NCT04675333ALX Oncology Inc.Phase 2Active not recruiting2025-03-03Actual
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)NCT04677179NKTRPhase 2Terminated2022-08-09Actual
Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19NCT04678830CytoDyn, Inc.Phase 2Completed2021-06-05Actual
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRSNCT04681066CALCPhase 2Completed2024-05-15Actual
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCNCT04681131BioAtla, Inc.Phase 2Completed2025-07-09Actual
HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)NCT04684914ALTPhase 2Terminated2024-03-27Actual
A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 TrialNCT04685993LPCNPhase 2Completed2022-03-01Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.